| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8486652 | Vaccine | 2017 | 7 Pages |
Abstract
The Flagellin/F1/V vaccine exhibited a dose dependent increase in immunogenicity and was well tolerated at all doses. Antibody specific responses to F1, V and flagellin increased as dose increased. Given the results from this trial, testing higher doses of the vaccine may be merited.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sharon E. Frey, Kathleen Lottenbach, Irene Graham, Edwin Anderson, Kanwaldeep Bajwa, Ryan C. May, Steven B. Mizel, Aaron Graff, Robert B. Belshe,